Evidence map›Paper›PMID 26976234›Full record

ArticleScientific reports2016

Targeted disruption of sp7 and myostatin with CRISPR-Cas9 results in severe bone defects and more muscular cells in common carp.

Zhaomin Zhong, Pengfei Niu, Mingyong Wang, Guodong Huang, Shuhao Xu, Yi Sun, Xiaona Xu, Yi Hou, Xiaowen Sun, Yilin Yan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Genome-Edited Fish in the Field.Current issues in molecular biology · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. 3 Biotech · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Zhaomin ZhongCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Pengfei NiuCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Mingyong WangCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Guodong HuangCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Shuhao XuCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Yi SunCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Xiaona XuCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Yi HouSchool of Biology &Basic Medical Sciences, Medical College, Soochow University, Suzhou 215123, Jiangsu, China.
Xiaowen SunHeilongjiang River Fisheries Research Institute of Chinese Academy of Fishery Sciences, Harbin, China.
Yilin YanCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Han WangCenter for Circadian Clocks, Soochow University, Suzhou 215123, Jiangsu, China.
Soochow University · CNChinese Academy of Fishery Sciences · CNUniversity of Oregon · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The common carp (Cyprinus carpio) as one of the most important aquaculture fishes produces over 3 million metric tones annually, approximately 10% the annual production of the all farmed freshwater fish worldwide. However, the tetraploidy genome and long generation-time of the common carp have made its breeding and genetic studies extremely difficult. Here, TALEN and CRISPR-Cas9, two versatile genome-editing tools, are employed to target common carp bone-related genes sp7, runx2, bmp2a, spp1, opg, and muscle suppressor gene mstn. TALEN were shown to induce mutations in the target coding sites of sp7, runx2, spp1 and mstn. With CRISPR-Cas9, the two common carp sp7 genes, sp7a and sp7b, were mutated individually, all resulting in severe bone defects; while mstnba mutated fish have grown significantly more muscle cells. We also employed CRISPR-Cas9 to generate double mutant fish of sp7a;mstnba with high efficiencies in a single step. These results demonstrate that both TALEN and CRISPR-Cas9 are highly efficient tools for modifying the common carp genome, and open avenues for facilitating common carp genetic studies and breeding.

Indexed as

CRISPR-Cas SystemsAnimalsBase SequenceBone and BonesCarpsFish ProteinsGene EditingModels, GeneticMusclesMutationMyostatinTranscription FactorsFish ProteinsMyostatinTranscription Factors

Identifiers

PMID26976234
PMCPMC4791634
OpenAlexW2298105180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.